Dexamethasone in joint arthroplasty

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042551

Enrollment

Unknown

Registered

2021-01-23

Start date

2021-01-21

Completion date

Unknown

Last updated

2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

joint arthroplasty

Interventions

control group:Not stated

Experimental group:Not stated

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age 18-85 years old, Weight 50-100 kg, BMI 18-40kg/m2.

Exclusion criteria

Exclusion criteria: Allergic to any studied drug, dhronic pain condition and severe peripheral neuropathy.

Design outcomes

Primary

Measure	Time frame
opioid consumption;Functional outcomes;complication;pain scores at rest (A) and with activity (B);TUG;ROM;Distance walked;single leg stand test;10-m walk test;KSS/HSS;	—

Countries

China

Contacts

Public ContactFeng Shuo

Affiliated Hospital of Xuzhou Medical University

xzfs0561@163.com+86 18552880088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026